Forecast & Rating4 analysts currently cover Eton Pharmaceuticals, of which 4 give a positive rating. The average price target is $71.00, about 20.6% upside from the current price of $58.86. Coverage is limited, so the data is for reference only. Data as of Aug 14, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$71.0020.63%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 9, 2026
Forecast met48.1%
Stock price$58.86
Avg. target$30.0
High target$35
Low target$26
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.